AAAAAA
Results:
1-12
|
Results: 12
Authors:
Marx, D
Frey, M
Zentgraf, H
Adelssen, G
Schauer, A
Kuhn, W
Meden, H
Citation: D. Marx et al., Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer, CANCER DET, 25(2), 2001, pp. 117-122
Authors:
Meden, H
Beneke, A
Hesse, T
Novophashenny, I
Wischnewsky, M
Citation: H. Meden et al., Weekly intravenous recombinant humanized anti-P185(HER2) monoclonal antibody (herceptin) plus docetaxel in patients with metastatic breast cancer: A pilot study, ANTICANC R, 21(2B), 2001, pp. 1301-1305
Authors:
Zupancic, K
Meden, H
Tomazevic, T
Znidarsic, V
Citation: K. Zupancic et al., The future law on infertility treatment and on biomedically assisted procreation in Slovenia, J AS REPROD, 17(9), 2000, pp. 496-497
Authors:
Bock, N
Meden, H
Regenbrecht, M
Junemann, B
Wangerin, J
Marx, D
Citation: N. Bock et al., Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast, ANTICANC R, 20(1A), 2000, pp. 119-124
Authors:
Schneider, J
Pollan, M
Jimenez, E
Marenbach, K
Martinez, N
Volm, M
Marx, D
Meden, H
Citation: J. Schneider et al., nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma, BR J CANC, 82(10), 2000, pp. 1662-1670
Authors:
Meden, H
Fattahi-Meibodi, A
Marx, D
Citation: H. Meden et al., ELISA-based quantification of p105 (c-erbB-2, HER2/neu) in serum of ovarian carcinoma, METH MOL M, 39, 2000, pp. 125-133
Authors:
Marx, D
Meden, H
Citation: D. Marx et H. Meden, Differential expression of apoptosis-associated genes bax and bcl-2 in ovarian cancer, METH MOL M, 39, 2000, pp. 687-691
Authors:
Gunthert, AR
Pilz, S
Kuhn, W
Emons, G
Meden, H
Citation: Ar. Gunthert et al., Docetaxel is effective in the treatment of metastatic endometrial cancer, ANTICANC R, 19(4C), 1999, pp. 3459-3461
Authors:
Schneider, J
Jimenez, E
Marenbach, K
Romero, H
Marx, D
Meden, H
Citation: J. Schneider et al., Immunohistochemical detection of HSP60-expression in human ovarian cancer.Correlation with survival in a series of 247 patients, ANTICANC R, 19(3A), 1999, pp. 2141-2146
Authors:
Pradier, O
Rave-Frank, M
Schmidberger, H
Bomecke, M
Lehmann, J
Meden, H
Hess, CF
Citation: O. Pradier et al., Effects of paclitaxel in combination with radiation on human head and neckcancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breastadenocarcinoma cells (MCF-7), J CANC RES, 125(1), 1999, pp. 20-27
Authors:
Busch, M
Meden, H
Meibodi, F
Duhmke, E
Kuhn, W
Citation: M. Busch et al., Long term results of definitive radiotherapy for cervical carcinoma using four applications of high dose rate afterloading, CANCER, 86(8), 1999, pp. 1520-1527
Authors:
Meden, H
Fattahi-Meibodi, A
Osmers, R
Krauss, T
Kuhn, W
Citation: H. Meden et al., Wertheim's hysterectomy after neoadjuvant carboplatin-based chemotherapy in patients with cervical cancer stage IIB and IIIB, ANTICANC R, 18(6B), 1998, pp. 4575-4579
Risultati:
1-12
|